{
  "id": 10464205,
  "title": "Roche cans muscle-preserving obesity drug, hands it back to Chugai",
  "url": "https://urgent.news/2026/09/28/roche-cans-muscle-preserving-obesity-drug-hands-it-back-to-chugai",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-28T14:06:16.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/roche-cans-muscle-preserving-obesity-drug-hands-it-back-to-chugai/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Roche has scrapped development of a muscle-building drug, ending a trial testing the experimental medicine in combination with an anti-obesity injectable. The Swiss pharma is stopping work on emugrobart, aptly named GYM329, and is returning ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}